news_6

Takeda’s LIVTENCITYTM (maribavir) Approved by U.S. FDA as the First and Only Treatment for People Ages 12 and Older with Post-Transplant Cytomegalovirus (CMV), Refractory (With or Without Genotypic Resistance) to Conventional Antiviral Therapies

news_6

Outlook on the Dental Diagnostic and Surgical Equipment Global Market to 2028 – Rising Awareness & Per Capita Income Presents Opportunities – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Dental Diagnostic And Surgical Equipment Market Size, Share & Trends Analysis Report By Product (Dental Diagnostic Equipment, Dental...